The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM).
 
Lucy Kennedy
No Relationships to Disclose
 
Amanda E.D. Van Swearingen
Stock and Other Ownership Interests - Abbott Laboratories; Abbott Laboratories (I); Cardinal Health; Cardinal Health (I); Health Care Select Sector; Health Care Select Sector (I); Invesco Dynamic Pharmaceuticals; Invesco Dynamic Pharmaceuticals (I); Merck; Merck (I); United Health Group; United Health Group (I)
 
Jeff Sheng
No Relationships to Disclose
 
Dadong Zhang
No Relationships to Disclose
 
Xiaodi Qin
No Relationships to Disclose
 
Eric S. Lipp
No Relationships to Disclose
 
Swaminathan Kumar
No Relationships to Disclose
 
Gao Zhang
No Relationships to Disclose
 
Brent Allen Hanks
Honoraria - Merck Sharp & Dohme; Novartis
Consulting or Advisory Role - G1 Therapeutics; Gerson Lehrman Group; Guidepoint Global
Speakers' Bureau - Merck; Novartis Institutes for BioMedical Research
Research Funding - AstraZeneca; D3; GlaxoSmithKline; Leap Therapeutics; Merck; Sanofi; Tempest Therapeutics
Patents, Royalties, Other Intellectual Property - Inhibiting paracrine Wnt ligand signaling to augment checkpoint inhibitor immunotherapy. (Inst); Modulating the metabolism of dendritic cells to enhance anti-tumor immunity. (Inst); Targeting the Tumor NLRP3 Inflammasome to Overcome Adaptive Resistance to Anti-PD-1 Antibody Immunotherapy
Expert Testimony - Duffy and Young; Kinnard, Clayton & Beveridge; LeClairRyan
Travel, Accommodations, Expenses - Cambridge Healthtech Institute
 
Michael A. Davies
Consulting or Advisory Role - Apexigen; Array BioPharma; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; NanoString Technologies; Novartis; Sanofi; Syndax; Vaccinex
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Kouros Owzar
Patents, Royalties, Other Intellectual Property - Patent applications through Duke University and University of North Carolina (Inst)
 
Carey K. Anders
Honoraria - AstraZeneca; Eisai; Elucida Oncology; Genentech/Roche; Immunomedics; IPSEN; Puma Biotechnology; Seagen
Consulting or Advisory Role - AstraZeneca; Eisai; Elucida Oncology; Genentech/Roche; Immunomedics; Ipsen; Puma Biotechnology; Seagen
Research Funding - G1 Therapeutics (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst); Tesaro (Inst); Zion Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlett; Up to Date.com
Travel, Accommodations, Expenses - Eisai
 
April K.S. Salama
Consulting or Advisory Role - Array BioPharma; Iovance Biotherapeutics; Novartis; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); Dynavax Technologies (Inst); Immunocore (Inst); Merck (Inst); Pfizer (Inst)